PSMC6 and ovarian carcinoma: In conclusion, the results obtained in this study support that PSMC6 plays a major role in the survival of ovarian carcinoma cells particularly in cisplatin-resistant cells of the endometrioid histotype, through a modulation of the MAPK pathways.